Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 11/2018

01-11-2018 | Research Article

The relationship between physician and cancer patient when initiating adjuvant treatment and its association with sociodemographic and clinical variables

Authors: P. Jimenez-Fonseca, C. Calderon, A. Carmona-Bayonas, M. M. Muñoz, R. Hernández, M. Mut Lloret, I. Ghanem, C. Beato, D. Cacho Lavín, A. Ivars Rubio, R. Carrión, C. Jara

Published in: Clinical and Translational Oncology | Issue 11/2018

Login to get access

Abstract

Purpose

The aim of this study was to analyze differences in physician and patient satisfaction in shared decision-making (SDM); patients’ emotional distress, and coping in subjects with resected, non-metastatic cancer.

Methods

602 patients from 14 hospitals in Spain were surveyed. Information was collected regarding physician and patient satisfaction with SDM, participants’ emotional distress and coping, as well as patient sociodemographic and clinical characteristics by means of specific, validated questionnaires.

Results

Overall, 11% of physicians and 19% of patients were dissatisfied with SDM; 22% of patients presented hopelessness or anxious preoccupation as coping strategies, and 56% presented emotional distress. By gender, female patients showed a higher prevalence of dissatisfaction with SDM (23 vs 14%), anxious preoccupation (26 vs 17%), and emotional distress (63 vs 44%) than males. Hopelessness was more prevalent in individuals with stage III disease than those with stages I–II (28 vs 18%).

Conclusion

Physicians must be mindful of the importance of emotional support and individual characteristics when communicating treatment options, benefits, and adverse effects of each alternative to oncological patients.
Literature
1.
Mitchell AJ, Chan M, Bhatti H, Halton M, Grassi L, Johansen C, et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol. 2011;12:160–74.CrossRef
2.
Travado L, Reis JC, Watson M, Borràs J. Psychosocial oncology care resources in Europe: a study under the European Partnership for Action Against Cancer (EPAAC). Psychooncology. 2017;530:523–30.CrossRef
3.
Grassi L, Berardi MA, Ruffilli F, Meggiolaro E, Andritsch E, Sirgo A, et al. Role of psychosocial variables on chemotherapy-induced nausea and vomiting and health-related quality of life among cancer patients: a European study. Psychother Psychosom. 2015;84:339–47.CrossRef
4.
Grassi L, Travado L, Moncayo FLG, Sabato S, Rossi E. Psychosocial morbidity and its correlates in cancer patients of the Mediterranean area: findings from the Southern European Psycho-Oncology Study. J Affect Disord. 2004;83:243–8.CrossRef
5.
Faller H, Weis J, Koch U, Brähler E, Härter M, Keller M, et al. Perceived need for psychosocial support depending on emotional distress and mental comorbidity in men and women with cancer. J Psychosom Res. 2016;81:24–30.CrossRefPubMed
6.
Ross L, Petersen MA, Johnsen AT, Lundstrøm LH, Groenvold M. Cancer patients’ evaluation of communication: a report from the population-based study ‘The Cancer Patient’s World’. Support Care Cancer. 2013;21:235–44.CrossRef
7.
Mathews M, Ryan D, Bulman D. What does satisfaction with wait times mean to cancer patients? BMC Cancer. 2015;15:1017.CrossRefPubMed
8.
De Vries AMM, Roten Y, Meystre C, Passchier J, Despland J, Stiefel F. Clinician characteristics, communication, and patient outcome in oncology: a systematic review. Psycho-Oncology. 2014;23:375–81.CrossRef
9.
Gilbar O, Zusman A. The correlation between coping strategies, doctor–patient/spouse relationships and psychological distress among women cancer patients and their spouses. Psycho-Oncology. 2007;16:1010–8.CrossRef
10.
Blanch-Hartigan D, Chawla N, Beckjord EI, Forsythe LP, de Moor JS, Hesse BW, et al. Cancer survivors’ receipt of treatment summaries and implications for patient-centered communication and quality of care. Patient Educ. 2015;98:1274–9.CrossRef
11.
Scholl I, Kriston L, Dirmaier J, Buchholz A, Härter M. Development and psychometric properties of the Shared Decision Making Questionnaire—physician version (SDM-Q-Doc). Patient Educ Couns. 2012;88:284–90.CrossRef
12.
Calderon C, Ferrando PJ, Carmona-Bayonas A, Lorenzo-Seva U, Jara C, Beato C, et al. Validation of SDM-Q-Doc Questionnaire to measure shared decision-making physician’s perspective in oncology practice. Clin Transl Oncol. 2017;19:1–8.CrossRef
13.
Kriston L, Scholl I, Hölzel L, Simon D, Loh A, Härter M. The 9-item Shared Decision Making Questionnaire (SDM-Q-9). Development and psychometric properties in a primary care sample. Patient Educ Couns. 2010;80:94–9.CrossRef
14.
De las Cuevas C, Perestelo-Perez L, Rivero-Santana A, Cebolla-Martí A, Scholl I, Härter M. Validation of the Spanish version of the 9-item Shared Decision-Making Questionnaire. Health Expect. 2015;18:2143–53.CrossRef
15.
Simon D, Schorr G, Wirtz M, Vodermaier A, Caspari C, Neuner B, et al. Development and first validation of the shared decision-making questionnaire (SDM-Q). Patient Educ Couns. 2006;63:319–27.CrossRef
16.
Watson M, Law MG, dos Santos M, Greer S, Baruch J, Bliss J. The Mini-MAC. J Psychosoc Oncol. 1994;12:33–46.CrossRef
17.
Anagnostopoulos F, Kolokotroni P, Spanea E, Chryssochoou M. The Mini-Mental Adjustment to Cancer (Mini-MAC) scale: construct validation with a Greek sample of breast cancer patients. Psycho-Oncology. 2006;15:79–89.CrossRef
18.
Vodermaier A, Linden W, Siu C. Screening for emotional distress in cancer patients: a systematic review of assessment instruments. J Natl Cancer Inst. 2009;101:1464–88.CrossRefPubMed
19.
Derogatis LR. BSI 18, Brief Symptom Inventory 18: administration, scoring and procedures manual. Minneapolis: NCS Pearson, Inc.; 2001.
20.
Andreu Y, Galdón MJ, Dura E, Ferrando M, Murgui S, García A, et al. Psychometric properties of the Brief Symptoms Inventory-18 (BSI-18) in a Spanish sample of outpatients with psychiatric disorders. Psicothema. 2008;20:844–50.
21.
Martín-Fernández R, Abt-Sacks A, Perestelo-Perez L, Serrano-Aguilar P. Shared decision making in breast cancer womens’ attitudes. Rev Esp Salud Publica. 2013;87:59–72.CrossRef
22.
Padilla-Garrido N, Correa FA, Moreno MO, Calero JB, Lozano EB. La toma de decisiones compartidas desde la perspectiva del paciente oncológico: roles de participación y valoración del proceso. An Sist Sanit Navar. 2017;40:25–33.
23.
Meggiolaro E, Berardi MA, Andritsch E, et al. Cancer patients’ emotional distress, coping styles and perception of doctor–patient interaction in European cancer settings. Palliat Support Care. 2016;14:204–11.CrossRef
24.
Jansen L, Hoffmeister M, Chang-Claude J, Brenner H, Arndt V. Benefit finding and post-traumatic growth in long-term colorectal cancer survivors: prevalence, determinants and associations with quality of life. Br J Cancer. 2011;105:1158–65.CrossRefPubMed
25.
Nenova M, DuHamel K, Zemon V, Rini C, Redd WH. Posttraumatic growth, social support, and social constraint in hematopoietic stem cell transplant survivors. Psychooncology. 2013;22:195–202.CrossRef
26.
Yi J, Kim MA. Postcancer experiences of childhood cancer survivors: how is posttraumatic stress related to posttraumatic growth? J Trauma Stress. 2014;27:461–7.CrossRef
27.
28.
Jacobsen PB, Holland JC, Steensma DP. Caring for the whole patient: the science of psychosocial care. J Clin Oncol. 2012;30:1151–3.CrossRef
29.
30.
Quinn GP, Gonçalves V, Sehovic I, Bowman ML, Reed DR. Quality of life in adolescent and young adult cancer patients: a systematic review of the literature. Patient Relat Outcome Meas. 2015;6:19–51.CrossRefPubMed
31.
Ng CG, Mohamed S, Kaur K, Sulaiman AH, Zainal NZ, Taib NA, et al. Perceived distress and its association with depression and anxiety in breast cancer patients. PLoS One. 2017;12:e0172975.CrossRefPubMed
32.
Linden W, Vodermaier A, MacKenzie R, Greig D. Anxiety and depression after cancer diagnosis: prevalence rates by cancer type, gender, and age. J Affect Disord. 2012;141:343–51.CrossRefPubMed
33.
Thorne S, Hislop TG, Kim-Sing C, Oglov V, Oliffe JL, Stajduhar KI. Changing communication needs and preferences across the cancer care trajectory: insights from the patient perspective. Support Care Cancer. 2014;22:1009–15.CrossRef
Metadata
Title
The relationship between physician and cancer patient when initiating adjuvant treatment and its association with sociodemographic and clinical variables
Authors
P. Jimenez-Fonseca
C. Calderon
A. Carmona-Bayonas
M. M. Muñoz
R. Hernández
M. Mut Lloret
I. Ghanem
C. Beato
D. Cacho Lavín
A. Ivars Rubio
R. Carrión
C. Jara
Publication date
01-11-2018
Publisher
Springer International Publishing
Published in
Clinical and Translational Oncology / Issue 11/2018
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-018-1870-z

Other articles of this Issue 11/2018

Clinical and Translational Oncology 11/2018 Go to the issue

Research Article

Radiotherapy volume delineation using 18F-FDG-PET/CT modifies gross node volume in patients with oesophageal cancer

Research Article

Concurrent chemoradiation for locally advanced stage III non-small cell lung cancer with cisplatin, vinorelbine, and thoracic radiotherapy: a phase II study from the Galician Lung Cancer Group

Research Article

Evaluation of thyroid gland as an organ at risk after breast cancer radiotherapy: a systematic review and meta-analysis

Research Article

Factors associated with anxiety and depression in cancer patients prior to initiating adjuvant therapy

Review Article

2018 consensus statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the diagnosis and treatment of cancer of unknown primary

Research Article

Prognostic and microRNA profile analysis for CD44 positive expression pediatric posterior fossa ependymoma
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits